Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Longboard Pharmaceuticals, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20
Revenues44.834.60.019.80.0
            Revenue growth 75.2%   
Cost of goods sold0.044.80.027.80.0
Gross profit44.8-10.20.0-8.10.0
            Gross margin100.0%-29.3% -40.8% 
Research and development34.6 19.8 4.6
General and administrative10.210.28.18.19.8
EBIT-44.8-44.8-27.8-27.8-14.4
            EBIT margin-100.0%-129.3% -140.8% 
Pre-tax income-43.9-43.9-27.8-27.8-14.4
Income taxes0.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%
Net income-43.9-43.9-27.8-27.8-14.4
            Net margin-98.1%-126.9% -140.6% 
 
Diluted EPS($2.56)($2.56)($1.93)($1.93)($3.78)
Shares outstanding (diluted)17.217.214.414.43.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy